Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Conditions

Dupuytren Contracture 4Rare Diseases 2Connective Tissue Diseases 2Arthritis 2

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Collagenases × Clear all
NCT02725528 2023-07-18

EXTEND

McMaster University

Phase 3 Completed
22 enrolled 15 charts

Dupuytren Contracture

NCT01450397 2017-04-17

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Hospital for Special Surgery, New York

Phase 4 Completed
5 enrolled 5 charts

Dupuytren Contracture

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed
36 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

NCT00014742 2015-03-25

Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 3 Completed
72 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡